ArticlePloS one2013

Serum soluble CD14 is a potential prognostic indicator of recurrence of human breast invasive ductal carcinoma with Her2-enriched subtype.

Weifeng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.